Remove 2023 Remove Digital Health Remove Health Technology Remove Pain management
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.

article thumbnail

Digital MSK is starting to fulfil its potential in 2024, IPO's likely in 2025

Lloyd Price

Exec Summary: The digital MSK (musculoskeletal) market is on the rise in 2024. MSK digital health solutions have raised $223M so far this year, already nearly double that of 2023’s $125M. from 2021 to 2028, driven by factors like increased adoption of digital health solutions and a need for more accessible MSK care.